Identification of Target Genes of Antiarrhythmic Traditional Chinese Medicine Wenxin Keli
Wenxin Keli (WXKL) is a traditional Chinese medicine drug approved for the treatment of cardiovascular diseases. This study aimed to identify WXKL-targeting genes involved in antiarrhythmic efficacy of WXKL. The Traditional Chinese Medicine Systems Pharmacology (TCMSP) technology platform was used t...
Saved in:
| Main Authors: | Yusi Yao, Yuhong Liu, Zhihuan Zeng, Yanqun Zhao, Tudi Li, Rong Chen, Rendan Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Cardiovascular Therapeutics |
| Online Access: | http://dx.doi.org/10.1155/2020/3480276 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of Lauric Acid as a Potent Sodium Channel NaV1.5 Blocker from Compound Chinese Medicine Wenxin Keli
by: Xie W, et al.
Published: (2025-01-01) -
Efficacy of Wenxin Keli Plus Amiodarone versus Amiodarone Monotherapy in Treating Recent-Onset Atrial Fibrillation
by: Nixiao Zhang, et al.
Published: (2018-01-01) -
Traditional Chinese medicine for cardiovascular disease: efficacy and safety
by: Youwei Lin, et al.
Published: (2024-12-01) -
Metabolomics advances in chronic atrophic gastritis diagnosis and the integration of traditional Chinese medicine
by: Yanqun Luo, et al.
Published: (2024-12-01) -
Present and future of antiarrhythmic therapy for atrial fibrillation: A review
by: Aida I. Tarzimanova
Published: (2024-11-01)